Table I.
Conditions Where Use of ABPM May Improve Patient Care
| Condition | Benefit | |
|---|---|---|
| Secondary (coenzyme A, coarctation of the aorta, renal) | ABPM may indicate greater chance for secondary causes | |
| Genetic risk for HTN | Evaluate patients with strong family history of HTN | |
| Williams & Turner syndrome may have stiff arteries | ||
| Neurofibromatosis 1 may have renal artery stenosis | ||
| White‐coat/masked HTN | Can be diagnosed only by ABPM | |
| Prehypertension | Confirm diagnosis | |
| Obesity | Rule out white‐coat and masked HTN especially with concomitant obstructive sleep apnea, polycystic ovary syndrome, or metabolic syndrome | |
| Risk for target organ damage | Can help determine whether imaging is needed | |
| Diabetes | Tight BP control reduces albuminuria | |
| Solid organ transplant | May uncover masked HTN or nighttime HTN | |
| Renal disease | Chronic renal insufficiency/transplant | Tighter 24‐h BP control to delay progression or prevent graft loss |
| Renal scarring | Abnormal ABPM correlates with renal scarring | |
Abbreviations: ABPM, ambulatory blood pressure monitoring; BP, blood pressure; HTN, hypertension.